India may give emergency authorisation of Oxford vaccine
November 22, 2020  15:39
image
India may grant emergency use authorisation of Oxford's coronavirus vaccine to Pune-based Serum Institute if AstraZeneca gets such approval from the UK government, Niti Aayog member Vinod Paul said on Saturday. He also said that if the clinical trials of the coronavirus vaccine in India go as per the script, phase III trials should be over by January-February 2021.

Vinod Paul, chairman of the National Expert Group on Vaccine Administration for Covid-19, said that the Indian drug regulator Drugs Controller General of India may consider giving emergency authorisation of Oxford's coronavirus vaccine to Adar Poonawalla's SII if AstraZeneca gets it in the UK.

"We expect emergency authorisation for Oxford-Astrazeneca vaccine to be sought in the UK. If so, it will give an opportunity for India regulator also," Vinod Paul said. If an emergency authorisation is granted in India before the phase 3 trials are completed, would make it possible that people in the priority list be administered early next year.
« Back to LIVE

TOP STORIES